Medicine shortage reports database
The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
MIN-I-JET ADRENALINE 1:10000 1mg/10mL injection pre-filled syringe
AUST R: 213983
Expected supply: 31 Aug 2025
Availability: Unavailable
Updated: 05-02-2020
AUST R: 14326
Expected supply: 01 Nov 2021
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 11-06-2021
AUST R: 14332
Expected supply: 31 May 2022
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 30-04-2021
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2022
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 18-06-2021
HEPATOLITE kit for production of Technetium(99mTc) disofenin powder for injection multidose vial
AUST R: 19146
Expected supply: Unknown
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 28-01-2020
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle
AUST R: 42975
Expected supply: 31 Jan 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 02-07-2021
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 50mg capsule bottle
AUST R: 42976
Expected supply: 31 Jan 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 02-07-2021
bupivacaine hydrochloride monohydrate
Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial
AUST R: 11314
Expected supply: 12 May 2021
Availability: Available
Updated: 25-06-2021
AUST R: 263913
Expected supply: 30 Jun 2021
Availability: Emergency Supply Only
Updated: 12-05-2021
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2021
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 11-06-2021
CIPLA BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial
AUST R: 220440
Expected supply: 30 Jun 2021
Availability: Unavailable
Updated: 22-09-2020
ETHYOL Amifostine (as trihydrate) 500mg powder for injection vial
AUST R: 63789
Expected supply: 31 Dec 2021
Availability: Unavailable
Updated: 03-12-2020
DBL SULFAMETHOXAZOLE 400 mg AND TRIMETHOPRIM 80 mg CONCENTRATE INJECTION BP 5mL injection ampoule
AUST R: 16293
Expected supply: 17 Dec 2021
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 13-07-2021
AUST R: 17589
Expected supply: Unknown
Availability: Unavailable
Updated: 30-06-2021
AUST R: 101670
Expected supply: 31 Dec 2021
Availability: Unavailable
Updated: 24-12-2020
MERIEUX INACTIVATED RABIES VACCINE 2.5IU powder for injection vial with diluent syringe
AUST R: 26675
Expected supply: 06 May 2021
Availability: Available
Updated: 07-05-2021
IMOGAM RABIES PASTEURIZED human rabies immunoglobulin 150 IU/mL injection vial
AUST R: 72931
Expected supply: 01 Jan 2021
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 21-10-2020
Suspended from ARTG - ZANTAC ranitidine 150mg/10mL (as hydrochloride) oral liquid bottle
AUST R: 35188
Expected supply: Unknown
Availability: Unavailable
Updated: 05-01-2021
tetracosactide (tetracosactrin)
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2021
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme.
Updated: 28-05-2021
AUST R: 16339
Expected supply: 05 Nov 2021
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 25-06-2021
Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4g/100mL) injection BP vial
AUST R: 10801
Expected supply: Unknown
Availability: Unavailable
Updated: 26-06-2020
Pfizer (Australia) ACICLOVIR INTRAVENOUS INFUSION aciclovir 250mg/10mL injection ampoule
AUST R: 66116
Expected supply: 30 Jun 2022
Availability: Unavailable
Updated: 18-08-2020
ASTRAZENECA SODIUM CHLORIDE 20% 2g/10mL injection BP ampoule
AUST R: 11983
Expected supply: Unknown
Availability: Available
Updated: 28-01-2020
CEFEPIME ALPHAPHARM cefepime (as hydrochloride) 2g powder for injection vial
AUST R: 161030
Expected supply: Unknown
Availability: Limited Availability
Updated: 24-02-2020
AUST R: 132525
Expected supply: 31 Dec 2020
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 25-11-2020
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 19 Jul 2021
Availability: Available
Updated: 19-07-2021
AUST R: 48374
Expected supply: 30 Aug 2021
Availability: Unavailable
Updated: 02-07-2021
AUST R: 72874
Expected supply: 30 Sep 2021
Availability: Unavailable
Updated: 02-07-2021
AUST R: 57993
Expected supply: 31 Mar 2021
Availability: Unavailable
Updated: 18-03-2021
AUST R: 72873
Expected supply: 30 Aug 2021
Availability: Unavailable
Updated: 02-07-2021
EPIRUBICIN ACCORD epirubicin hydrochloride 200mg/100mL concentrated injection vial
AUST R: 227997
Expected supply: 30 Sep 2021
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 27-11-2020
procaine benzylpenicillin (procaine penicillin)
CILICAINE SYRINGE 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe
AUST R: 288818
Expected supply: 19 Nov 2021
Availability: Unavailable
Updated: 26-05-2021
AUST R: 72876
Expected supply: 30 Sep 2021
Availability: Unavailable
Updated: 26-11-2020
AUST R: 72875
Expected supply: 30 Sep 2021
Availability: Unavailable
Updated: 26-11-2020
MARCAIN 0.25% EPIDURAL INFUSION bupivacaine hydrochloride (as monohydrate) 250mg/100mL injection bag
AUST R: 11953
Expected supply: 30 Sep 2021
Availability: Unavailable
Updated: 26-11-2020
AUST R: 13705
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 06-07-2021
HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial
AUST R: 272644
Expected supply: 15 Oct 2021
Availability: Unavailable
Updated: 08-07-2021
adrenaline (epinephrine) acid tartrate
ADRENALINE-LINK 1:1,000 1mg/1mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 12048
Expected supply: 03 Sep 2021
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 11-06-2021
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 05 Jul 2021
Availability: Available
Updated: 05-07-2021
AUST R: 235933
Expected supply: 06 Dec 2021
Availability: Limited Availability
Updated: 06-04-2021
naloxone hydrochloride dihydrate
JUNALOX naloxone hydrochloride (as dihydrate) 400 micrograms/1 mL solution for injection, ampoule
AUST R: 236004
Expected supply: Unknown
Availability: Available
Management action: An alternate brand by the same sponsor is currently available - Naloxone Juno 400 micrograms / 1 mL solution for injection, ampoule - ARTG 236005
Updated: 08-02-2021
SPAN K potassium chloride 600 mg tablet bottle (new formulation)
AUST R: 328843
Expected supply: 07 Jun 2021
Availability: Available
Updated: 07-06-2021
AUST R: 238265
Expected supply: Unknown
Availability: Available
Updated: 24-02-2021
VORICONAZOLE APOTEX voriconazole 200 mg powder for injection vial
AUST R: 265660
Expected supply: 25 Feb 2022
Availability: Limited Availability
Updated: 26-07-2021
AUST R: 184745
Expected supply: 29 Oct 2021
Availability: Unavailable
Updated: 30-07-2021
FRESOFOL 1% MCT/LCT propofol 200mg/20mL emulsion for intravenous injection/infusion ampoule
AUST R: 193608
Expected supply: 07 May 2021
Availability: Available
Updated: 11-05-2021
AUST R: 159342
Expected supply: 30 Sep 2021
Availability: Unavailable
Management action: Alternative unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 26-07-2021
FLEBOGAMMA 5% DIF normal immunoglobulin (Human) 5g/100mL intravenous use injection vial
AUST R: 143801
Expected supply: 03 Aug 2021
Availability: Available
Updated: 03-08-2021
MIOCHOL-E acetylcholine chloride 20mg/2mL powder for solution for intraocular irrigation ampoule
AUST R: 118510
Expected supply: 31 Oct 2021
Availability: Unavailable
Updated: 20-07-2021
FLEBOGAMMA 5% DIF normal immunoglobulin (Human) 10g/200mL intravenous use injection vial
AUST R: 143802
Expected supply: 03 Aug 2021
Availability: Available
Updated: 03-08-2021
FLEBOGAMMA 5% DIF normal immunoglobulin (Human) 20g/400mL intravenous use injection vial
AUST R: 143803
Expected supply: 03 Aug 2021
Availability: Available
Updated: 03-08-2021
ANSTO Health Chromium (51Cr) Edetate 8MBq/mL injection BP vial
AUST R: 22779
Expected supply: 17 May 2021
Availability: Available
Updated: 20-05-2021
TOFRANIL 10 imipramine hydrochloride 10mg tablet blister pack
AUST R: 11064
Expected supply: 31 Aug 2021
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 19-07-2021
ERTAPENEM KABI ertapenem (as sodium) 1 g powder for injection vial
AUST R: 294975
Expected supply: 31 May 2021
Availability: Available
Updated: 03-06-2021
PHARMORUBICIN RD (RAPID DISSOLUTION) epirubicin hydrochloride 50mg powder for injection vial
AUST R: 40220
Expected supply: 31 Dec 2021
Availability: Available
Updated: 20-04-2021
magnesium sulfate heptahydrate
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION 2.47g/5mL injection ampoule
AUST R: 16311
Expected supply: 31 May 2022
Availability: Available
Updated: 19-04-2021
RIFADIN rifampicin 600mg powder for injection vial with diluent ampoule
AUST R: 156919
Expected supply: 10 May 2021
Availability: Available
Updated: 05-05-2021
AUST R: 12513
Expected supply: 14 May 2021
Availability: Available
Updated: 10-05-2021
CLEXANE enoxaparin sodium 20mg/0.2mL injection syringe with safety lock system
AUST R: 221717
Expected supply: 07 Jun 2021
Availability: Available
Updated: 07-06-2021
CLEXANE enoxaparin sodium 40mg/0.4mL injection syringe with automatic safety lock system
AUST R: 221718
Expected supply: 17 Jun 2021
Availability: Available
Management action: Whilst there is sufficient stock to cover normal national demand, wholesaler ordering limits are temporarily in place to help ensure a smooth transition to normal stock levels.
For further information regarding Clexane supply, please contact Sanofi Customer Service on 1800 640 791.
Updated: 17-06-2021
PRIORIX-TETRA vaccine 0.5mL powder for injection vial with diluent syringe
AUST R: 107286
Expected supply: 16 Aug 2021
Availability: Only available under NIP or government programs
Updated: 16-07-2021
CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle
AUST R: 307429
Expected supply: 31 Jan 2022
Availability: Limited Availability
Updated: 21-05-2021
ROPIVACAINE KABI ropivacaine hydrochloride 400 mg/200 mL solution for infusion bag
AUST R: 195811
Expected supply: 11 Jun 2021
Availability: Available
Updated: 11-06-2021
HEPARIN SODIUM 25000IU/5mL (porcine mucous) injection ampoule
AUST R: 49236
Expected supply: 08 Oct 2021
Availability: Available
Updated: 03-08-2021
ACETYLCYSTEINE-LINK INJECTION acetylcysteine 2g/10mL concentrated injection ampoule
AUST R: 170803
Expected supply: 19 Jul 2021
Availability: Available
Updated: 20-07-2021
DBL Aciclovir 250mg/10mL Intravenous infusion injection vial
AUST R: 56809
Expected supply: 21 Jul 2021
Availability: Available
Updated: 21-07-2021
DBL ACETYLCYSTEINE injection concentrate acetylcysteine 2 g/ 10 mL injection ampoule
AUST R: 121503
Expected supply: 29 Oct 2021
Availability: Available
Updated: 28-07-2021
CARBOSORB X activated charcoal 50 g/250 mL suspension bottle
AUST R: 106470
Expected supply: 20 Sep 2021
Availability: Limited Availability
Updated: 13-07-2021
AUST R: 335999
Expected supply: 31 Aug 2021
Availability: Limited Availability
Updated: 14-07-2021
AUSTRALIAN RADIOISOTOPES Sodium Iodide (I-131) 50 - 6000MBq Therapy Capsule vial
AUST R: 22808
Expected supply: 18 Oct 2021
Availability: Available
Management action: During the period from 09 September to 01 October 2021, limited supply of the I-131 products will be available to customers. To ensure minimal impact, ANSTO has been in consultation with the nuclear medicine working group to optimise the activity and the size of the product during the period of limited supply (from 09 Sep-01 October).
For the period from 02 Oct to 18 October 2021, I-131 products won't be available for supply from ANSTO. It is estimated that ANSTO won’t be able to supply the Australian Domestic Market with approximately 200,000MBq or about 165 patient doses of Iodine-131 Capsules.
Updated: 23-07-2021
Sodium iodide(131I) 2000MBq/mL Therapy Solution oral liquid BP vial
AUST R: 48267
Expected supply: 18 Oct 2021
Availability: Available
Management action: During the period from 09 September to 01 October 2021, limited supply of the I-131 products will be available to customers. To ensure minimal impact, ANSTO has been in consultation with the nuclear medicine working group to optimise the activity and the size of the product during the period of limited supply (from 09 Sep-01 October).
For the period from 02 Oct to 18 October 2021, I-131 products won't be available for supply from ANSTO. It is estimated that ANSTO won’t be able to supply the Australian Domestic Market with approximately 11,400MBq of Iodine-131 Solution (2000MBq/mL size solution product).
Updated: 23-07-2021
Sodium iodide(131I) 200MBq/mL Therapy Solution oral liquid BP vial
AUST R: 22807
Expected supply: 18 Oct 2021
Availability: Available
Management action: During the period from 09 September to 01 October 2021, limited supply of the I-131 products will be available to customers. To ensure minimal impact, ANSTO has been in consultation with the nuclear medicine working group to optimise the activity and the size of the product during the period of limited supply (from 09 Sep-01 October).
For the period from 02 Oct to 18 October 2021, I-131 products won't be available for supply from ANSTO. It is estimated that ANSTO won’t be able to supply the Australian Domestic Market with approximately 10,000MBq of Iodine-131 Solution (200MBq/mL size solution product).
Updated: 23-07-2021
DBL CIPROFLOXACIN 200 mg/100 mL injection for intravenous infusion bag
AUST R: 123041
Expected supply: 20 Aug 2021
Availability: Available
Updated: 30-07-2021
Haemophilus influenza type B polyribose ribitol phosphate
Hepatitis B surface antigen recombinant
Pertussis filamentous haemagglutinin
INFANRIX HEXA injection composite pack (pre-filled syringe and vial)
AUST R: 132881
Expected supply: 23 Aug 2021
Availability: Unavailable
Updated: 02-08-2021
PREGNYL gonadotrophin - chorionic human 1500IU powder for injection vial with diluent vial
AUST R: 273873
Expected supply: Unknown
Availability: Unavailable
Updated: 03-08-2021
PREGNYL gonadotrophin - chorionic human 5000IU powder for injection vial with diluent vial
AUST R: 273874
Expected supply: Unknown
Availability: Unavailable
Updated: 03-08-2021
tetracosactide (tetracosactrin)
SYNACTHEN tetracosactide (tetracosactrin) 0.25mg/1mL injection ampoule
AUST R: 11058
Expected supply: 18 Aug 2021
Availability: Unavailable
Updated: 03-08-2021
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/